Replies to post #426088 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

Sub $7.75 expected by EOD for more reloading

That's all well and good for those who are so fortunate as to deep financial pockets to potentially mitigate their AVXL losses by averaging down. However, looking at the big picture, the AVXL strategy to delay progress on potential AD regulatory approval in order to gamble on Rett EXCELLENCE success with the attendant $100 million voucher, is really negatively impacting AVXL shareholders for the time being. I suspect a quarterly earnings update with no news will embolden the shorts to take AVXL even lower.